GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » EPS (Diluted)

Qianhai Health Holdings (HKSE:00911) EPS (Diluted) : HK$-0.31 (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings EPS (Diluted)?

Qianhai Health Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.35. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.31.

Qianhai Health Holdings's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.31.

Qianhai Health Holdings's EPS without NRI for the six months ended in Dec. 2023 was HK$0.35. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.31.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Qianhai Health Holdings's highest 3-Year average EPS without NRI Growth Rate was -46.40% per year. The lowest was -70.80% per year. And the median was -58.60% per year.


Qianhai Health Holdings EPS (Diluted) Historical Data

The historical data trend for Qianhai Health Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings EPS (Diluted) Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 -0.01 -0.01 -1.38 -0.31

Qianhai Health Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.12 -1.50 -0.66 0.35

Competitive Comparison of Qianhai Health Holdings's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's PE Ratio falls into.



Qianhai Health Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Qianhai Health Holdings's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-52.705-0)/169.445
=-0.31

Qianhai Health Holdings's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(59.413-0)/169.445
=0.35

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianhai Health Holdings  (HKSE:00911) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Qianhai Health Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings (HKSE:00911) Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Hou Chung Man 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Lim Tzea 2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines